<DOC>
	<DOCNO>NCT01040585</DOCNO>
	<brief_summary>The therapy Linezolid ( LIN ) represent well cost-effectiveness vs. Vancomycin ( VAN ) treatment nosocomial Pneumonia associate ventilator ( VAP ) .</brief_summary>
	<brief_title>Cost Effectiveness Of Linezolid In Central America</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<criteria>Evidence legally acceptable representative sign date informed consent document indicate informed pertinent aspect study . Adult ( 18 year old old ) men woman confirm diagnosis VAP treat ICU LIN VAN ; select institution . Adult men woman nosocomial pneumonia associate ventilator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>cost effectiveness</keyword>
	<keyword>linezolid</keyword>
	<keyword>ventilator acquire pneumonia</keyword>
	<keyword>central america</keyword>
</DOC>